Press Release Details

Female executive
Investor Relations Investors news releases news release details AMN Healthcare Announces Second Quarter 2018 Results

AMN Healthcare Announces Second Quarter 2018 Results

August 2, 2018
Quarterly revenue of $558 million, up 14% over prior year; GAAP EPS of $0.73 and adjusted EPS of $0.83

SAN DIEGO, Aug. 2, 2018 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services, today announced its second quarter 2018 financial results. Financial highlights are as follows:

Dollars in millions, except per share amounts.

 

Q2 2018

% Change
Q2 2017

YTD  June
30, 2018

% Change
YTD  June
30, 2017

Revenue

$558.1

14%

$1,080.6

10%

Gross profit

$181.0

12%

$348.8

8%

Net income

$35.5

14%

$78.2

24%

Diluted EPS

$0.73

16%

$1.60

25%

Adj. diluted EPS*

$0.83

24%

$1.64

26%

Adjusted EBITDA*

$70.1

4%

$136.6

5%

 

*  See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "Supplemental Financial and Operating Data" for a reconciliation of non-GAAP items.

Highlights

  • AMN Healthcare reached record highs for revenue and adjusted EPS in the quarter.
  • Second quarter consolidated revenue of $558 million increased 14% year over year, with organic growth of 7%.
  • Growth was led by our Nurse and Allied Solutions segment with revenue up by 11% year over year.
  • Adjusted EBITDA of $70 million grew 4% year over year and was 12.6% of revenue.
  • Operating cash flow in the second quarter was $66 million. In the first half of 2018, cash flow from operations totaled $126 million, up 80% year over year.
  • The April acquisitions of MedPartners, Phillips DiPisa and Leaders For Today contributed $36 million of revenue in the quarter.

"Solid execution in the second quarter enabled AMN to reach all-time highs in revenue and adjusted EBITDA. We continue to expand and add new MSP clients and have a strong pipeline," said Susan R. Salka, Chief Executive Officer of AMN Healthcare. "Our team delivered well for Nurse and Allied clients, with strong fill rates amid a relatively tepid demand environment and pricing headwinds. Solid performance in several of our businesses is being offset by a decline in Locum Tenens, where we continue to see below-market performance due to the disruption from business model and technology changes made earlier this year. Our recent acquisitions are integrating with the AMN family and are off to a good start. The primary macro drivers of our industry appear favorable for the foreseeable future, and we remain confident in the long-term growth of AMN."

Second Quarter 2018 Results

Consolidated revenue for the quarter was $558 million, a 14% increase over prior year and 7% higher than prior quarter. Revenue for the Nurse and Allied Solutions segment was $333 million, higher by 11% year over year and down 2% sequentially. The quarter included $25 million of labor disruption revenue. Excluding this event, segment revenue grew 2% year over year and seasonally declined 9% sequentially, in line with expectations. Growth of the Travel Nurse division was in line with expectations with revenue up 2% year over year, driven by a volume increase partly offset by a lower mix of premium-rate assignments. Allied division revenue increased 7% year over year, driven primarily by volume increases.

The Locum Tenens Solutions segment reported revenue of $107 million, down by 1% year over year, with lower volumes being offset by positive pricing. Other Workforce Solutions segment revenue was $118 million reflecting an increase of 46% year over year, with the benefit of acquisitions made in April 2018. Organic growth of 2% year over year was driven by the mid-revenue cycle and interim leadership businesses.

Gross margin was 32.4%, lower by 50 basis points year over year and higher by 30 basis points sequentially. The variances were positively impacted by higher-than-average gross margins from the recently acquired companies and a change in our physician permanent placement business model that prompted a recording of certain recruiter expenses in SG&A that were previously in cost of revenue. These positives were partly offset by a below-average labor disruption gross margin. Net of these factors, our year-over-year gross margin declined primarily due to a lower margin in our Nurse and Allied and Other Workforce Solutions segments.

SG&A expenses were $116 million, or 20.7% of revenue, compared with $97 million, or 19.7% of revenue, in the same quarter last year. SG&A was $105 million, or 20.0% of revenue, in the previous quarter. The increase in expenses and expense margin was impacted by added costs from the recently acquired companies and the physician permanent placement cost change.

Net income was $36 million, or $0.73 per diluted share, compared with $31 million, or $0.63 per diluted share, in the same quarter last year. Adjusted diluted EPS was $0.83. Adjusted EBITDA was $70 million, a year-over-year increase of 4%. Adjusted EBITDA margin was 12.6%, representing a decrease of 110 basis points year over year and a decrease of 10 basis points sequentially.

At June 30, 2018, cash and cash equivalents totaled $23 million. Cash flow from operations was $66 million for the quarter, and capital expenditures were $11 million. AMN repurchased 385,000 shares of stock for $21 million during the quarter. The Company ended the quarter with total debt outstanding of $480 million, with a leverage ratio as calculated in accordance with the Company's credit agreement of 1.7 to 1.

Third Quarter 2018 Outlook

Metric

Guidance*

Consolidated revenue

$522 - $530 million

Gross margin

~33.0%

SG&A as percentage of revenue

 ~21.5%

Adjusted EBITDA margin

~12.5%

 

*Note: Guidance percentage metrics are approximate.  For a reconciliation of adjusted EBITDA margin, see the table entitled "Reconciliation of Guidance Adjusted EBITDA Margin to Guidance Operating Margin" below.

Projected year-over-year revenue growth in the third quarter of 2018 is approximately 6-7%. On an organic basis, revenue is projected to be down approximately 1% due primarily to disruption in the Locum Tenens business and a mix shift away from premium-rate assignments in Travel Nursing. No significant labor disruption revenue is included in third quarter guidance.

Conference Call on August 2, 2018

AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforce solutions and staffing services, will host a conference call to discuss its second quarter 2018 financial results on Thursday, August 2, 2018, at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/eventcalendar. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9959 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company's website. Alternatively, a telephonic replay of the call will be available starting at 7:30 p.m. Eastern Time on August 2, 2018, and can be accessed until 11:59 p.m. Eastern Time on August 16, 2018, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 451076.

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, mid-revenue cycle solutions, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry.

The Company's common stock is listed on the New York Stock Exchange under the symbol "AMN." For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication ("RSS") as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://amnhealthcare.investorroom.com/emailalerts.

Non-GAAP Measures

This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company's condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin and (3) adjusted diluted EPS.  The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company's operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly titled non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company's performance.  A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled "Supplemental Financial and Operating Data" under the caption entitled "Reconciliation of Non-GAAP Items" and the footnotes thereto or on the Company's website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company's website.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our guidance for third quarter 2018 revenue, gross margin, SG&A expenses as a percentage of revenue, adjusted EBITDA margin and long-term trends for our business. The Company bases these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may," "estimates," variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in our fillings with the Securities and Exchange Commission (SEC), including our most recent Annual Report on Form 10-K for the year ended December 31, 2017, our subsequent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated and the Company is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

Contact:
Randle Reece
Director, Investor Relations
866.861.3229

AMN Healthcare Services, Inc.

Condensed Consolidated Statements of Comprehensive Income

(in thousands, except per share amounts)

(unaudited)

 
 

Three Months Ended

 

Six Months Ended

 

June 30,

 

March 31,

 

June 30,

 

2018

 

2017

 

2018

 

2018

 

2017

Revenue

$

558,108

 

$

489,803

 

$

522,489

 

$

1,080,597

 

$

984,972

Cost of revenue

377,152

 

328,791

 

354,665

 

731,817

 

662,184

Gross profit

180,956

 

161,012

 

167,824

 

348,780

 

322,788

Gross margin

32.4%

 

32.9%

 

32.1%

 

32.3%

 

32.8%

Operating expenses:

                 

Selling, general and administrative (SG&A)

115,535

 

96,673

 

104,737

 

220,272

 

198,746

SG&A as a % of revenue

20.7%

 

19.7%

 

20.0%

 

20.4%

 

20.2%

                   

Depreciation and amortization

10,606

 

7,959

 

7,886

 

18,492

 

15,627

Total operating expenses

126,141

 

104,632

 

112,623

 

238,764

 

214,373

Income from operations

54,815

 

56,380

 

55,201

 

110,016

 

108,415

Operating margin (1)

9.8%

 

11.5%

 

10.6%

 

10.2%

 

11.0%

                   

Interest expense, net, and other

6,376

 

4,928

 

5,335

 

11,711

 

10,058

                   

Income before income taxes

48,439

 

51,452

 

49,866

 

98,305

 

98,357

                   

Income tax expense

12,910

 

20,197

 

7,185

 

20,095

 

35,094

Net income

$

35,529

 

$

31,255

 

$

42,681

 

$

78,210

 

$

63,263

Net income as a % of revenue

6.4%

 

6.4%

 

8.2%

 

7.2%

 

6.4%

                   

Other comprehensive income (loss):

                 

Foreign currency translation and other

91

 

(41)

 

(19)

 

72

 

(38)

Cash flow hedge, net of income taxes

 

(58)

 

 

 

(15)

Other comprehensive income (loss)

91

 

(99)

 

(19)

 

72

 

(53)

                   

Comprehensive income

$

35,620

 

$

31,156

 

$

42,662

 

$

78,282

 

$

63,210

                   

Net income per common share:

                 

Basic

$

0.75

 

$

0.65

 

$

0.89

 

$

1.64

 

$

1.32

Diluted

$

0.73

 

$

0.63

 

$

0.87

 

$

1.60

 

$

1.28

Weighted average common shares outstanding:

                 

Basic

47,653

 

47,916

 

47,733

 

47,693

 

47,849

Diluted

48,936

 

49,475

 

49,116

 

49,026

 

49,498

 

AMN Healthcare Services, Inc.

Supplemental Financial and Operating Data

(dollars in thousands, except per share data and operating data)

(unaudited)

 
 

Three Months Ended

 

Six Months Ended

 

June 30,

 

March 31,

 

June 30,

 

2018

 

2017

 

2018

 

2018

 

2017

Revenue

                 

Nurse and allied solutions

$

332,728

   

$

300,727

   

$

338,179

   

$

670,907

   

$

614,250

 

Locum tenens solutions

107,297

   

108,215

   

103,117

   

210,414

   

211,058

 

Other workforce solutions

118,083

   

80,861

   

81,193

   

199,276

   

159,664

 
 

$

558,108

   

$

489,803

   

$

522,489

   

$

1,080,597

   

$

984,972

 
                   

Reconciliation of Non-GAAP Items:

                 
                   

Segment operating income (2)

                 

Nurse and allied solutions

$

43,936

   

$

47,851

   

$

51,805

   

$

95,741

   

$

93,831

 

Locum tenens solutions

13,371

   

12,371

   

9,958

   

23,329

   

24,590

 

Other workforce solutions

28,576

   

22,041

   

19,851

   

48,427

   

41,898

 
 

85,883

   

82,263

   

81,614

   

167,497

   

160,319

 

Unallocated corporate overhead

15,823

   

15,080

   

15,095

   

30,918

   

29,971

 

Adjusted EBITDA (3)

70,060

   

67,183

   

66,519

   

136,579

   

130,348

 

Adjusted EBITDA margin (4)

12.6%

   

13.7%

   

12.7%

   

12.6%

   

13.2%

 
                   

Depreciation and amortization

10,606

   

7,959

   

7,886

   

18,492

   

15,627

 

Share-based compensation

3,281

   

2,562

   

2,864

   

6,145

   

5,243

 

Acquisition and integration costs

1,358

   

282

   

568

   

1,926

   

1,063

 

Income from operations

54,815

   

56,380

   

55,201

   

110,016

   

108,415

 

Interest expense, net, and other

6,376

   

4,928

   

5,335

   

11,711

   

10,058

 

Income before income taxes

48,439

   

51,452

   

49,866

   

98,305

   

98,357

 

Income tax expense

12,910

   

20,197

   

7,185

   

20,095

   

35,094

 

Net Income

$

35,529

   

$

31,255

   

$

42,681

   

$

78,210

   

$

63,263

 
                   

GAAP diluted net income per share (EPS)

$

0.73

   

$

0.63

   

$

0.87

   

$

1.60

   

$

1.28

 

Adjustments:

                 

Amortization of intangible assets

0.13

   

0.09

   

0.09

   

0.22

   

0.19

 

Acquisition and integration costs

0.02

   

0.01

   

0.01

   

0.03

   

0.02

 

Debit financing related costs

   

   

0.01

   

0.01

   

 

Tax effect on above adjustments

(0.04)

   

(0.04)

   

(0.03)

   

(0.07)

   

(0.08)

 

Tax correction related to prior periods (5)

   

   

(0.05)

   

(0.05)

   

 

Excess tax benefits (6)

(0.01)

   

(0.02)

   

(0.09)

   

(0.10)

   

(0.11)

 

Adjusted diluted EPS (7)

$

0.83

   

$

0.67

   

$

0.81

   

$

1.64

   

$

1.30

 

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

March 31,

 

June 30,

 

2018

 

2017

 

2018

 

2018

 

2017

Gross Margin

                 

Nurse and allied solutions

26.3

%

 

27.8

%

 

28.0

%

 

27.2

%

 

27.7

%

Locum tenens solutions

29.8

%

 

30.0

%

 

28.7

%

 

29.2

%

 

30.3

%

Other workforce solutions

52.2

%

 

55.7

%

 

53.6

%

 

52.7

%

 

55.3

%

                   
                   

Operating Data:

                 

Nurse and allied solutions

                 

Average healthcare
professionals on assignment (8)

9,095

   

8,776

   

9,567

   

9,331

   

8,913

 
                   

Locum tenens solutions

                 

Days filled (9)

55,225

   

58,660

   

52,794

   

108,020

   

113,903

 

Revenue per day filled (10)

$

1,943

   

$

1,845

   

$

1,953

   

$

1,948

   

$

1,853

 

 

 

As of June 30,

 

As of March 31,

 

2018

 

2017

 

2018

Leverage ratio (11)

1.7

   

1.4

 

1.2

 

AMN Healthcare Services, Inc.

Condensed Consolidated Balance Sheets

(dollars in thousands)

(unaudited)

 
 

June 30,
2018

 

December 31,
2017

 

June 30,
2017

Assets

         

Current assets:

         

Cash and cash equivalents

$

22,894

   

$

15,147

   

$

22,878

 

Accounts receivable, net

354,781

   

350,496

   

334,597

 

Accounts receivable, subcontractor

34,657

   

41,012

   

36,631

 

Prepaid and other current assets

56,189

   

67,498

   

46,938

 

Total current assets

468,521

   

474,153

   

441,044

 

Restricted cash, cash equivalents and investments

61,839

   

64,315

   

33,882

 

Fixed assets, net

81,221

   

73,431

   

65,368

 

Other assets

83,034

   

74,366

   

71,594

 

Goodwill

439,134

   

340,596

   

340,596

 

Intangible assets, net

339,514

   

227,096

   

236,486

 

Total assets

$

1,473,263

   

$

1,253,957

   

$

1,188,970

 
           

Liabilities and stockholders' equity

         

Current liabilities:

         

Accounts payable and accrued expenses

$

123,105

   

$

130,319

   

$

118,943

 

Accrued compensation and benefits

130,258

   

121,423

   

107,283

 

Current portion of notes payable

 

 

18,071

 

Deferred revenue

13,615

   

8,384

   

9,644

 

Other current liabilities

16,261

   

5,146

   

12,387

 

Total current liabilities

283,239

   

265,272

   

266,328

 
           

Revolving credit facility

155,000

   

   

 

Notes payable, less unamortized fees

320,225

   

319,843

   

319,462

 

Deferred income taxes, net

19,863

   

27,036

   

12,387

 

Other long-term liabilities

78,192

   

79,279

   

82,301

 

Total liabilities

856,519

   

691,430

   

680,478

 
           

Commitments and contingencies

         
           

Stockholders' equity:

616,744

   

562,527

   

508,492

 
           

Total liabilities and stockholders' equity

$

1,473,263

   

$

1,253,957

   

$

1,188,970

 

 

AMN Healthcare Services, Inc.

Summary Condensed Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

 
 

Three Months Ended

 

Six Months Ended

 

June 30,

 

March 31,

 

June 30,

 

2018

 

2017(12)

 

2018

 

2018

 

2017(12)

               

Net cash provided by operating activities

$

66,203

   

$

25,359

   

$

59,735

   

$

125,938

   

$

70,043

 

Net cash used in investing activities

(229,337)

   

(6,316)

   

(9,613)

   

(238,950)

   

(19,616)

 

Net cash provided by (used in) financing activities

133,627

   

(26,945)

   

(14,970)

   

118,657

   

(38,873)

 

Effect of exchange rates on cash

91

   

(42)

   

(19)

   

72

   

(38)

 

Net increase (decrease) in cash, cash equivalents and restricted cash

(29,416)

   

(7,944)

   

35,133

   

5,717

   

11,516

 

Cash, cash equivalents and restricted cash at beginning of period

134,027

   

70,488

   

98,894

   

98,894

   

51,028

 

Cash, cash equivalents and restricted cash at end of period

$

104,611

   

$

62,544

   

$

134,027

   

$

104,611

   

$

62,544

 

 

AMN Healthcare Services, Inc.

Additional Supplemental Non-GAAP Disclosures

Reconciliation of Guidance Adjusted EBITDA Margin to

Guidance Operating Margin

(unaudited)

 
 

Three Months Ended

 

September 30, 2018

   

Adjusted EBITDA margin(13)

12.5%

Deduct:

 

Share-based compensation

0.6%

Acquisition and integration costs

0.2%

EBITDA margin

11.7%

Depreciation and amortization

2.1%

Operating margin

9.6%

   

(1)

Operating margin represents income from operations divided by revenue.

(2)

Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs and share-based compensation.

(3)

Adjusted EBITDA represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, acquisition and integration costs and share-based compensation. Management believes that adjusted EBITDA provides an effective measure of the Company's results, as it excludes certain items that management believes are not indicative of the Company's operating performance and is a measure used in the Company's credit agreement and the indenture governing our 5.125% Senior Notes due 2024. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.

(4)

Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.

(5)

During the first quarter of 2018, the Company recorded a net tax benefit of $2,501,000 to adjust for an immaterial out-of-period error identified this quarter related to the income tax treatment of fair value changes in the cash surrender value of its Company Owned Life Insurance for years ended December 31, 2015 through December 31, 2017. These fair value changes had not previously been included as a benefit in the tax provision of the related years.

(6)

The consolidated effective tax rate for the three and six months ended June 30, 2018 was favorably affected by the recording of excess tax benefits relating to equity awards vested and exercised during the period. As a result of the adoption of a new accounting pronouncement on January 1, 2017, we no longer record excess tax benefits as an increase to additional paid-in capital, but record such excess tax benefits on a prospective basis as a reduction of income tax expense, which amounted to $576,000 and $1,028,000 for the three months ended June 30, 2018 and 2017, respectively. For the six months ended June 30, 2018 and 2017, excess tax benefits recorded as a reduction of income tax expense were $5,094,000 and $5,325,000, respectively. The magnitude of the impact of excess tax benefits generated in the future, which may be favorable or unfavorable, is dependent upon the Company's future grants of share-based compensation, the Company's future stock price on the date awards vest or exercise in relation to the fair value of the awards on the grant date or the exercise behavior of the Company's stock appreciation rights holders. Since these favorable tax benefits are largely unrelated to our current year's income before taxes and is unrepresentative of our normal effective tax rate, we excluded their impact on adjusted diluted EPS for the three months and six months ended June 30, 2018 and 2017.

(7)

Adjusted diluted EPS represents GAAP diluted EPS excluding the impact of the (A) amortization of intangible assets, (B) acquisition and integration costs, (C) deferred financing costs, (D) tax effect, if any, of the foregoing adjustments, (E) excess tax benefits relating to equity awards vested and exercised since January 1, 2017, and (F) correction of prior periods error. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company's operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparison between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from adjusted diluted EPS). Although management believes the items excluded from adjusted diluted EPS are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.

(8)

Average healthcare professionals on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.

(9)

Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.

(10)

Revenue per day filled represents revenue of the Company's locum tenens solutions segment divided by days filled for the period presented.

(11)

Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company's credit agreement) at the end of the subject period to the consolidated adjusted EBITDA (as calculated per the Company's credit agreement) for the twelve-month period ended at the end of the subject period.

(12)

As a result of the adoption of ASU 2016-18, "Statement of Cash Flows (Topic 230): Restricted Cash" on January 1, 2018, we are required to present in the statement of cash flows the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. We adjusted certain restricted cash amounts for the three and six months ended June 30, 2017 in the cash flow table presented above. These adjustments had no effect on previously reported results of operations or retained earnings.

(13)

Guidance percentage metrics are approximate.

 

SOURCE AMN Healthcare Services, Inc.